Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Aclaris Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(2) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Fees to Be Paid
| Equity | Common Stock, $0.00001 par value per share | Rule 457(c) and Rule 457(r) | — | — | $200,000,000 | 0.00011020 | $ 22,040 | — | — | — | — | ||||||||||||
Fees Previously Paid
| — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities
| — | — | — | — | — | — | — | — | — | — | — | |||||||||||||
Total Offering Amounts | $200,000,000 | — | $22,040 | — | — | — | — | |||||||||||||||||
Total Fees Previously Paid | — | — | — | — | — | — | ||||||||||||||||||
Total Fee Offsets | — | — | — | — | — | — | ||||||||||||||||||
Net Fee Due | — | $22,040 | — | — | — | — |
(1) | Consists of shares to be issued pursuant to that Sales Agreement, or the Sales Agreement, dated February 23, 2023, between Aclaris Therapeutics, Inc. and SVB Securities LLC and Cantor Fitzgerald & Co. |
(2) | The registration fee relates to the Registration Statement on Form S-3ASR (File No. 333-256337) filed by the Registrant on May 20, 2021. |